NISHIYAMA Hiroyuki
- Articles
- This Issue 32-12
Nishiyama Hiroyuki
International journal of urology : official journal of the Japanese Urological Association/32(12)/p.1723, 2025-12-01 - Longitudinal Impact of Urinary Diversion on Health-Related Quality of Life After Radical Cystectomy: A Multicenter Study in Japan
Yamada Shuhei; Sato Miho; Osawa Takahiro; Harabayashi ...
CANCER SCIENCE, 2026-01-04 - Revealing intra-group immunotherapy response heterogeneity in metastatic urothelial carcinoma through interpretable feature extraction and spectral clustering
Nagumo Yoshiyuki; Ye Xiucai; Shi Tianyi; Mathis Bryan...
FRONTIERS IN IMMUNOLOGY/16, 2026-01-06 - Age-stratified outcomes of radical cystectomy for muscle-invasive bladder cancer: a nationwide multicenter study of 1867 patients in Japan
Kawai Taketo; Miki Jun; Taoka Rikiya; Saito Ryoichi; ...
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2026-01-16 - Incidence, risk factors, and clinical implications of enfortumab vedotinrelated cutaneous toxicity in urothelial carcinoma: a large-scale, real-world study in Japan
Kita Y.; Hara T.; Kawahara T.; Hashimoto K.; Matsushi...
ESMO REAL WORLD DATA AND DIGITAL ONCOLOGY/7, 2025-03 - Real-World Comparison of Survival Outcomes Between Radical Cystectomy and Intravesical Bacillus Calmette-Guérin (BCG) Therapy in BCG-Naïve or -Unresponsive Non-Muscle-Invasive Bladder Cancer
Miyake Makito; Nishimura Nobutaka; Taoka Rikiya; Miki ...
INTERNATIONAL JOURNAL OF UROLOGY, 2025-12-12 - Outcomes of sequential therapy for advanced upper tract urothelial cancer and bladder cancer
Kanesaka Manato; Sazuka Tomokazu; Kita Yuki; Fukuhara ...
SCIENTIFIC REPORTS/15(1), 2025-11-25 - Health-related quality of life (HRQoL) outcomes from the NIAGARA trial of perioperative durvalumab (D) plus neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC)
van der Heijden M. S.; Powles T. B.; Galsky M. D.; Cat...
ANNALS OF ONCOLOGY/36(2), 2025-09 - Bladder preservation therapy in combination with atezolizumab and radiation therapy (BPT-ART) for invasive bladder cancer: Final analysis from a multicenter, open-label, prospective phase II trial
Nagumo Y.; Kimura T.; Ishikawa H.; Sekino Y.; Maruo ...
ANNALS OF ONCOLOGY/36(2), 2025-09 - A randomized controlled phase III trial on continued or paused PD-1 pathway blockade for patients with advanced renal cell carcinoma (JCOG1905, STOP study): a study protocol
Matsumoto Takashi; Tanegashima Tokiyoshi; Takeuchi Ari...
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2025-12-01 - Clinical and histopathological features of alopecia associated with enfortumab vedotin treatment
Oya Kazumasa; Ishii Yoshiyuki; Anju Keisuke; Takano A...
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY/(41328716), 2025-12-02 - Real-World Outcomes of Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Results From the Final Analysis of Postmarketing Surveillance
Kikuchi Eiji; Nagata Masayoshi; Ito Taito; Sato Masas...
CANCER MEDICINE/14(21), 2025-10-30 - Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Subgroup Analyses of Post-Marketing Surveillance Data by Age, Prior Chemotherapy Regimen, and Best Overall Response to Prior Chemotherapy
Nagata Masayoshi; Kikuchi Eiji; Ito Taito; Sato Masas...
CANCER MEDICINE/14(21), 2025-10-30 - Automated EMG-Based Classification of Upper Extremity Motor Impairment Levels in Subacute Stroke
Anastasiev Alexey; Kadone Hideki; Marushima Aiki; Wata...
Sensors/25(22), 2025-11 - Protocol summary of a randomized controlled phase III trial for confirming the superiority of local radiotherapy for prostate cancer patients with high-volume metastasis sensitive to hormonal therapy: the JCOG2011 (HimeRT study)
Terada Naoki; Nihei Keiji; Aizawa Rihito; Narita Shin...
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2025-10-06 - Trends in the use of perioperative therapy and effects of adjuvant immunotherapy on prognosis for muscle-invasive urothelial carcinoma: A multicenter study
Hatakeyama S.; Fujita N.; Kobayashi M.; Kandori S.; I...
EUROPEAN UROLOGY/87(1), 2025-03 - Effects of neoadjuvant chemotherapy and lymph node dissection on oncological outcomes of radical cystectomy for non-muscle-invasive bladder cancer: Results from a nationwide Japanese database JUOG-UC-2021-RC
Sano T.; Taoka R.; Miki J.; Saito R.; Fukuokaya W.; ...
EUROPEAN UROLOGY/87(1), 2025-03 - Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial
De Santis Maria; Palou Redorta Joan; Nishiyama Hiroyuki; ...
Lancet (London, England)/406(10516)/pp.2221-2234, 2025-10-17 - Adverse Events in Testicular Cancer Survivors Using EORTC QLQ-TC26: A Multi-Institutional, Cross-Sectional Study in Japan
Goto Takuro; Yamashita Shinichi; Kakimoto Kenichi; Uemura...
International journal of urology : official journal of the Japanese Urological Association, 2025-10-17 - Branched-Chain Amino Acids and Testosterone in Older Adults With Type 2 Diabetes: Cross-Sectional and Longitudinal Findings From a Post Hoc Analysis of an Amino Acid Supplementation Trial
Matsuda Erika; Matsuda Takaaki; Kojo Kosuke; Osaki Yo...
Cureus/17(9), 2025-09-01 - Comprehensive Fertility Management After Pituitary Adenoma Surgery: Lessons from a Rural Japanese Case and Practical Review
Numahata Daisuke; Kojo Kosuke; Ishikawa San-E; Kuramae T...
Reports (MDPI)/8(3), 2025-08-15 - Renal Prognostic Identification in Patients With Autosomal Dominant Polycystic Kidney Disease by Whole Genome Sequencing: A Prospective, Observational Study
Kai Hirayasu; Usui Joichi; Okada Eri; Ishii Ryota; Sato ...
Kidney medicine/7(9), 2025-09-01 - ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
Powles Thomas; Kann Ariel G; Castellano Daniel; Gross-Gou...
The New England journal of medicine, 2025-10-20 - Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer
Isoda Bunpei; Shiga Masanobu; Kandori Shuya; Takahashi...
Cancer research communications/5(9)/pp.1681-1689, 2025-09-01 - PD37-09 The First Report Of Disease-Free Survival Analyses From The Niagara Trial Of Perioperative Durvalumab Plus Neoadjuvant Chemotherapy In Muscle-Invasive Bladder Cancer: Erratum
Meeks Joshua J; van der Heijden Michiel S; Powles Thom...
The Journal of urology/214(5)/p.556, 2025-11-01 - more...
- This Issue 32-12